Serum alanine aminotransferase and its association with metabolic syndrome in children: The bogalusa heart study

Metabolic Syndrome and Related Disorders

Volumn 9, Issue 3, 2011, Pages 211-216

  Patel, Dharmendrakumar A ^a   Srinivasan, Sathanur R ^b   Chen, Wei ^b   Berenson, Gerald S ^b  

^a OCHSNER CLINIC FOUNDATION   (United States)

^b Tulane Center for Cardiovascular Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADOLESCENT; ADULT; AGE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BODY MASS; CHILD; CHOLESTEROL BLOOD LEVEL; CLINICAL STUDY; CROSS-SECTIONAL STUDY; FEMALE; GENDER; HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE; HUMAN; MALE; METABOLIC SYNDROME X; MODEL; NORMAL HUMAN; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; RACE; SCHOOL CHILD; SYSTOLIC BLOOD PRESSURE;

ADOLESCENT; ADULT; ALANINE TRANSAMINASE; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HEART DISEASES; HUMANS; LOUISIANA; MALE; METABOLIC SYNDROME X; YOUNG ADULT;

EID: 79957637365     PISSN: 15404196     EISSN: 15578518     Source Type: Journal    
DOI: 10.1089/met.2010.0086     Document Type: Article

References (40)

1. Clark JM, Brancati FL, Diehl AM. The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol 2003;98:960-967. (Pubitemid 36733754)
2. Clark JM, Diehl AM. Nonalcoholic fatty liver disease: An underrecognized cause of cryptogenic cirrhosis. JAMA 2003;289:3000-3004. (Pubitemid 37430103)
3. Lavine JE, Schwimmer JB. NAFLD in the pediatric population. Clin Liver Dis 2004,8:549-558.
4. Wieckowska, Feldstein AE. Non alcoholic fatty liver disease in the pediatric population: A review. Curr Opin Pediatr 2005;17:636-641.
5. Strauss RS, Barlow SE, Dietz WH. Prevalence of abnormal serum aminotransferase values in overweight and obese adolescents. J Pediatr 2000;136:727-733. (Pubitemid 30415644)
6. Schwimmer JB, Deutsch R, Rauch JB, Behling C, Newbury R, Lavine JE. Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease. J Pediatr 2003;143:500-505. (Pubitemid 37352510)
7. Kotronen A, Yki-Jarvinen H. Fatty liver: A novel component of the metabolic syndrome. Aeterioscler Thromb Vasc Biol 2008;28:27-38.
8. Schindhelm RK, Dekker JM, Nijpels G, Bouter LM, Stehouwer CD, Heine RJ, Diamant M. Alanine aminotransferase predicts coronary heart disease events:A10-year followup of the Hoorn Study. Atherosclerosis 2007;191:391-396. (Pubitemid 46400701)
9. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, McCullough AJ, Natale S, Forlani G, Melchionda N. Nonalcoholic fatty liver disease: A feature of the metabolic syndrome. Diabetes 2001;50:1844-1850. (Pubitemid 33641605)
10. Hanley AJ, Williams K, Festa A, Wagenknecht LE, D'Agostino RB Jr, Haffner SM. Liver Markers and development of the metabolic syndrome: The Insulin Resistance Atherosclerosis Study. Diabetes 2005;54:3140-3147. (Pubitemid 43334367)
11. Saviano MC, Brunetti F, Rubino A, Franzese A, Vajro P, Argenziano A, Puzziello A, Iannucci MP. Liver involvement in obese children. Ultrasonography and liver enzyme levels at diagnosis and during follow-up in an Italian population. Dig Dis Sci 1997;42:1428-1432. (Pubitemid 27339358)
12. The Bogalusa Heart Study 20th anniversary symposium. Am J Med Sci 1995;(suppl 1):S1-138.
13. Srinivasan SR, Berenson GS. Serum lipoproteins in children and methods for study. In: Lewis LA (ed). Handbook of Electrophoresis. Boca Raton, FL: CRC; 1983: 185-204
14. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419. (Pubitemid 15018832)
15. Ford ES, Li C. Defining the metabolic syndrome in children and adolescents: Will the real definition please stand up? J Pediatr 2008;152:165-170.
16. Steinberger J, Daniels SR, Eckel RH, Hayman L, Lustig RH, McCrindle B, Mietus-Snyder ML. Progress and challenges in metabolic syndrome in children and adolescents: A scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; and Council on Nutrition, Physical Activity, and Metabolism. Circulation 2009;119:628-647.
17. Srinivasan SR, Myers L, Berenson GS. Predictability of childhood adiposity and insulin for developing insulin resistance syndrome (Syndrome X) in young adults: The Bogalusa Heart Study. Diabetes 2002;51:204-209. (Pubitemid 34517999)
18. Chen W, Srinivasan SR, Li S, Xu JH, Berenson GS. Metabolic syndrome variables at low levels in childhood are beneficially associated with adulthood cardiovascular risk. The Bogalusa Heart Study. Diabetes Care 2005;28:138-144.
19. Hosmer DW, Lemeshow S. Applied Logistic Regression, 2nd ed. New York: John Wiley and Sons; 2000.
20. Schwimmer JB, McGreal N, Deutsch R, Finegold MJ, Lavine JE. Influence of gender, race, and ethnicity on suspected fatty liver in obese adolescents. Pediatrics 2005;115:561-565.
21. Rashid M, Roberts EA. Nonalcoholic steatohepatitis in children. J Pediatr Gastroenterol Nutr 2000;30:48-53. (Pubitemid 30349945)
22. Deutsch MI, Mueller WH, Malina RM. Adrogeny in fat patterning is associated with obesity in adolescents and young adults. Am J Hum Biol 1985;12:275-286. (Pubitemid 15123738)
23. Schwimmer JB, Khorram O, Chiu V, Schwimmer WB. Abnormal aminotransferase activity in women with polycystic ovary syndrome. Fertil Steril 2005;83:494-497. (Pubitemid 40221817)
24. Chen W, Bao W, Begum S, Elkasabany A, Srinivasan SR, Berenson GS. Age-related patterns of the clustering of cardiovascular risk variables of syndrome X from childhood to young adulthood in a population made up of black and white subjects: The Bogalusa Heart Study. Diabetes 2000;49: 1042-1048. (Pubitemid 30349428)
25. Smith CP, Dunger DB, Williams AJK, Taylor AM, Perry LA, Gale EA, Preece MA, Savage MO. Relationship between insulin, insulin-like growth factor 1, and dehydroepiandrosterone sulfate concentrations during children, puberty, and adult life. J Clin Endocrinol Metab 1989;68:932-937. (Pubitemid 19127412)
26. Srinivasan SR, Freedman DS, Sundaram GS, Webber LS, Berenson GS. Racial (black-white) comparisons of the relationship of levels of endogenous sex hormones to serum lipoproteins during male adolescence: The Bogalusa Heart Study. Circulation 1986;74:1226-1234. (Pubitemid 17189241)
27. Jiang X, Srinivasan SR, Dalferes ER Jr, Berenson GS. Plasma insulin-like growth factor-1 distribution and its relation to blood pressure in adolescents: The Bogalusa Heart Study. Am J Hypertens 1997;10:714-719. (Pubitemid 27313816)
28. Frisancho AR, Flegel PN. Advanced maturation associated with centripetal fat pattern. Hum Biol 1982;54:717-727. (Pubitemid 13117033)
29. Berenson GS, Srinivasan SR, Cresanta JL, Foster TA, Webber LS. Dynamic changes of serum lipoproteins in children during adolescence and sexual maturation. Am J Epidemiol 1981;113:157-170. (Pubitemid 11183757)
30. Amiel SA, Sherwin RS, Simonson DC, Lauritano AA, Tamborlane WV. Impaired insulin action in puberty. N Engl J Med 1986;315:215-219.
31. Caprio S, Plewe G, Diamond MP, Simonson DC, Boulware SD, Sherwin RS, Tamborlane WV. Increased insulin secretion in puberty: A compensatory response to reductions in insulin sensitivity. J Pediatr 1989;114:963-967. (Pubitemid 19151751)
32. Sinaiko A, Donahue RP, Jacobs DR, Prineas RJ. Relation of weight and rate of increase in weight during childhood and adolescence to body size, blood pressure, fasting insulin, and lipids in young adults. The Minneapolis Children's Blood Pressure Study. Circulation 1999;99:1471-1476. (Pubitemid 29140914)
33. Bloomgarden ZT. Non alcoholic fatty liver disease and malignancy as complications of insulin resistance. Metabol Syndr Rel Disord 2005;3:316-327.
34. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003;112:1796-1808. (Pubitemid 38063703)
35. Matsuzawa Y, Funahashi T, Kihara S, Shimomura I. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol 2004;24:29-33. (Pubitemid 38082408)
36. Kern PA, Di Gregorio GB, Lu T, Rassouli N, Ranganathan G. Adiponectin expression from human adipose tissue-relation to obesity, insulin resistance, and tumor necrosis factor-a expression. Diabetes 2003;52:1779-1785. (Pubitemid 36792470)
37. Angulo P. Non-alcoholic fatty liver disease. N Engl J Med, 2002, 346:1221-1231.
38. Angelico F, Del Ben M, Conti R, Francioso S, Feole K, Maccioni D, Antonini TM, Alessandri C. Non-alcoholic fatty liver syndrome: a hepatic consequence of common metabolic diseases. J Gastroenterol Hepatol 2003;18:588-594. (Pubitemid 36645294)
39. Freedman DS, Srinivasan SR, Valdez RA, Williamson DF, Berenson GS. Secular increase in relative weight and adiposity among children over two decades: The Bogalusa Heart Study. Pediatrics 1997;99:420-426. (Pubitemid 27176016)
40. Ogden CL, Flegal KM, Carroll MD, Johnson CL. Prevalence and trends in overweight among U.S. children and adolescents 1999-2000. JAMA 2002;288:1728-1732.